Importantly, the pathological diagnosis of AML requires co‐expression of melanocytic (e.g., HMB‐45) and muscle‐related markers [e.g., αSMA (α smooth muscle actin)] (Folpe & Kwiatkowski, 2010). The gene discussed is PMEL; the disease is acute myeloid leukemia.